Connect with us

Tofranil (imipramine)

Imipramine (or TOFRANIL®) is mainly prescribed to treat major depressive disorder and enuresis.

Status: ACTIVE

Class: Tricyclic (TCA)

FDA Approval: 1976

Dosage Forms: 10 mg, 25 mg, 50 mg, 75 mg, 100 mg, 125 mg, 150 mg

Biological Half-life: 20 hours

Side Effects: Dizziness, nausea, blurred vision, confusion, headache, anxiety, weakness, insomnia, increased appetite, tachycardia, high blood pressure, skin rash, increased suicide risk

Routes of Administration: Oral, IM

Pregnancy Category: N (US)


Twitter Feed

Gene discovery may explain why Lithium doesn't work for all patients

Researchers found insomnia may increase risk of mood disorder in teens #mentalhealth @PittTweet

Can Tylenol provide relief for social media anxiety? #FOMO #socialanxiety #cyberpsychology